Editors Choice

Breakthrough Infections Dramatically Enhance COVID Immunity

I don’t want anyone to get Covid after being fully vaccinated, a so-called “breakthrough infection.” I wish they would never happen. The reality is, however, breakthrough infections do happen. And, it seems, they are happening more often this Fall.

This is not totally surprising. While it would be ideal for a vaccine to prevent infection – i.e., catching the virus at all – at the very least, a good vaccine will prevent you from getting very sick from the disease. On this latter front, the vaccines continue to hold up well.

Yet, if it were to happen – if someone were to get a breakthrough infection – research shows that this person ends up with very robust immunity.

Researchers from the Oregon Health & Science University studied 26 people who were fully vaccinated against SARS CoV-2 and subsequently got COVID and compared them with 26 people who were vaccinated but did not get COVID. They found the immunity after a breakthrough infection was substantial:

Data showing substantially enhanced immunity after breakthrough infection. Source: JAMA

In fact, the immunity after a breakthrough infection helped protect against multiple variants of SARS CoV-2, including Delta (the study was conducted before Omicron was born):

Immunity after a breakthrough infection was substantial against multiple variants, including Delta. Source: JAMA

This is also not surprising, as an infection after vaccination serves as a “booster shot,” of sorts, and it therefore greatly enhances one’s immunity.

Now, of course, this is not the best way to boost your immunity against COVID if you are vaccinated. Sometimes, even mild COVID infections can have lasting long-term effects.

The best way, in fact, to boost your immunity against COVID is to get a booster shot. In the United States, everyone over the age of 16 is eligible to get a booster shot 2 months after the J&J vaccine and 6 months after the mRNA vaccines. They are safe. They are effective. And they boost your immunity to a great degree.

Again, I do not wish a breakthrough infection on anyone. This disease is horrible, and I have seen its horror up close. If one does get a breakthrough, though, the silver lining is that the immunity after such infection is very, very robust.

Reference: Bates TA, McBride SK, Winders B, et al. Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection. JAMA. Published online December 16, 2021. doi:10.1001/jama.2021.22898

Dr. Hesham A. Hassaballa

Dr. Hesham A. Hassaballa is a NY Times featured Pulmonary and Critical Care Medicine specialist in clinical practice for over 20 years. He is Board Certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine, and Sleep Medicine. He is a prolific writer, with dozens of peer-reviewed scientific articles and medical blog posts. He is a Physician Leader and published author. His latest book is "Code Blue," a medical thriller.

Recent Posts

Your Trail Is a Toxic Path: How Hiking & Outdoor Gear Are Seeding Plastic Into Our Bodies

I spent many summers on Long Island when it was still a forest wonderland of…

4 days ago

Anti-Intelligence: The Map That Forgot the Territory

There’s a line I’ve always loved: “The map is not the territory.” Alfred Korzybski wrote…

4 days ago

Two Gatherings, One Mission: Elevating Life Science Leadership and Communication

Every industry has its signature gatherings, places where thought leaders assemble to shape the next…

7 days ago

SUICIDE: IS AI RESPONSIBLE?

The Raines discovered their son Adam in the closet where he hung himself with the…

2 weeks ago

Beds, Forests and the Price of Credibility at COP30

On a damp, equatorial morning in Belém, the river smells faintly of diesel and guava. Vendors…

2 weeks ago

Inside the High-Stakes Battle Over Vaccine Injury Compensation, Autism, and Public Trust

[Reprinted with permission from KFF Health News. Authored by Céline Gounder] Department of Health and…

2 weeks ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More